JP2023505316A5 - - Google Patents
Info
- Publication number
- JP2023505316A5 JP2023505316A5 JP2022534275A JP2022534275A JP2023505316A5 JP 2023505316 A5 JP2023505316 A5 JP 2023505316A5 JP 2022534275 A JP2022534275 A JP 2022534275A JP 2022534275 A JP2022534275 A JP 2022534275A JP 2023505316 A5 JP2023505316 A5 JP 2023505316A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962944735P | 2019-12-06 | 2019-12-06 | |
| US62/944,735 | 2019-12-06 | ||
| PCT/US2020/062893 WO2021113365A1 (en) | 2019-12-06 | 2020-12-02 | Nanomaterials |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023505316A JP2023505316A (ja) | 2023-02-08 |
| JPWO2021113365A5 JPWO2021113365A5 (https=) | 2023-11-30 |
| JP2023505316A5 true JP2023505316A5 (https=) | 2023-11-30 |
| JP7699128B2 JP7699128B2 (ja) | 2025-06-26 |
Family
ID=76209418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022534275A Active JP7699128B2 (ja) | 2019-12-06 | 2020-12-02 | ナノマテリアル |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20210169804A1 (https=) |
| EP (1) | EP4069675A4 (https=) |
| JP (1) | JP7699128B2 (https=) |
| KR (1) | KR20220113737A (https=) |
| AU (1) | AU2020396940A1 (https=) |
| CA (1) | CA3160395A1 (https=) |
| WO (1) | WO2021113365A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12569438B2 (en) | 2019-07-29 | 2026-03-10 | Georgia Tech Research Corporation | Nanomaterials containing constrained lipids and uses thereof |
| US12435035B2 (en) | 2020-01-09 | 2025-10-07 | Guide Therapeutics, Llc | Nanomaterials |
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| JP2023546175A (ja) | 2020-10-14 | 2023-11-01 | ジョージ・メイソン・リサーチ・ファウンデーション・インコーポレイテッド | 脂質ナノ粒子製造の方法及びそれに由来する組成物 |
| WO2022140239A1 (en) * | 2020-12-21 | 2022-06-30 | Beam Therapeutics Inc. | Nanomaterials comprising carbonates |
| IL303845A (en) | 2021-01-20 | 2023-08-01 | Beam Therapeutics Inc | Nanomaterials include a degradable property |
| KR20230131863A (ko) | 2021-01-20 | 2023-09-14 | 빔 테라퓨틱스, 인크. | 나노물질 |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| US20250346554A1 (en) * | 2021-12-16 | 2025-11-13 | Jsr Corporation | Method for purifying composition |
| CN114436994B (zh) * | 2022-01-26 | 2024-02-27 | 中国药科大学 | 金刚烷尾链脂质及其在细胞转染中的应用 |
| EP4532713A1 (en) | 2022-05-27 | 2025-04-09 | Beam Therapeutics Inc. | Identification of nanoparticles for preferential tissue or cell targeting |
| EP4543847A2 (en) * | 2022-06-23 | 2025-04-30 | Turn Biotechnologies, Inc. | Lipid structures and compositions comprising same |
| WO2024019936A1 (en) | 2022-07-20 | 2024-01-25 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
| JP2025539561A (ja) * | 2022-12-12 | 2025-12-05 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | 新規な脂質化合物及びそれを含む脂質ナノ粒子組成物 |
| US12311033B2 (en) | 2023-05-31 | 2025-05-27 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| CN119490447A (zh) * | 2023-08-17 | 2025-02-21 | 苏州星核迪赛生物技术有限公司 | 药物递送材料及其应用 |
| WO2025076049A1 (en) * | 2023-10-03 | 2025-04-10 | Broadpharm Inc. | Lipid compounds, lipid nanoparticles, and pharmaceutical compositions |
| WO2026035680A1 (en) | 2024-08-06 | 2026-02-12 | Kernal Biologics, Inc. | Compositions and methods for delivery of agents |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL257307A (https=) * | 1959-10-28 | |||
| US3686238A (en) * | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| DE102007029471A1 (de) | 2007-06-20 | 2008-12-24 | Novosom Ag | Neue fakultativ kationische Sterole |
| ES2895651T3 (es) * | 2013-12-19 | 2022-02-22 | Novartis Ag | Lípidos y composiciones lipídicas para la administración de agentes activos |
| EP3727362A4 (en) * | 2017-12-19 | 2021-10-06 | PureTech LYT, Inc. | MYCOPHENOLIC ACID LIPID PRODRUGS AND THEIR USES |
| US20210300962A1 (en) * | 2018-08-02 | 2021-09-30 | Puretech Lyt, Inc. | Lipid prodrugs of pregnane neurosteroids and uses thereof |
| US12594339B2 (en) * | 2019-02-28 | 2026-04-07 | Seaport Therapeutics, Inc. | Lipid prodrugs of JAK inhibitors and uses thereof |
| WO2020176868A1 (en) * | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of btk inhibitors and uses thereof |
| WO2020176856A1 (en) * | 2019-02-28 | 2020-09-03 | Puretech Lyt, Inc. | Lipid prodrugs of glucocorticoids and uses thereof |
| US12569438B2 (en) * | 2019-07-29 | 2026-03-10 | Georgia Tech Research Corporation | Nanomaterials containing constrained lipids and uses thereof |
-
2020
- 2020-12-02 JP JP2022534275A patent/JP7699128B2/ja active Active
- 2020-12-02 US US17/110,070 patent/US20210169804A1/en not_active Abandoned
- 2020-12-02 CA CA3160395A patent/CA3160395A1/en active Pending
- 2020-12-02 EP EP20895707.6A patent/EP4069675A4/en active Pending
- 2020-12-02 WO PCT/US2020/062893 patent/WO2021113365A1/en not_active Ceased
- 2020-12-02 KR KR1020227022734A patent/KR20220113737A/ko active Pending
- 2020-12-02 AU AU2020396940A patent/AU2020396940A1/en active Pending
-
2024
- 2024-05-24 US US18/673,962 patent/US20250000797A1/en active Pending